ZMUni Compliance Centre

  On August 6, China officially issued its first mandatory national standard for cosmetics the GB 7916-2026 Cosmetics—General Safety Requirements, drafted under the organization of the National Medical Products Administration (NMPA). The standard will come into force on January 1, 2028. Following the implementation of the new standard, the GB 7916-1987 Hygienic Standard for Cosmetics, which was introduced in 1987, will be abolished accordingly.   The issuance of GB 7916-2026 marks a significant update to China's cosmetic safety standard system. Regulatory focus will further shift from traditional "hygiene management" toward full lifecycle safety management, covering all stages from raw materials, formulation,

  On August 6, 2026, China's National Institute for Drug Control (NIDC) issued a notice seeking public comments on nine cosmetic standards. The proposed revisions cover the following areas:     Addition of New Prohibited Cosmetic Ingredients   Three existing cosmetic ingredients are proposed to be added to the List of Prohibited Cosmetic Ingredients (Table 1) under the Safety and Technical Standards for Cosmetics (STSC).   Updates to Ingredient Restrictions, Labeling Requirements, and Hair Dye Requirements   The proposed revisions include new restrictions, updated labeling requirements, and expanded permitted uses for certain colorants.   Introduction of a New Cosmetic Safety

At ZMUni, we value the trust and feedback of our partners as an important reflection of our professional services and long-term cooperation.   Recently, three partners from South Korea's beauty industry shared their recognition of ZMUni's regulatory support and project execution capabilities. Representing different segments of the beauty industry—a skincare brand, a cosmetics manufacturer, and an international beauty company—these collaborations demonstrate the diverse regulatory challenges companies may encounter when entering the China market.   From addressing regulatory changes and managing registration processes to preparing technical documentation for efficacy-based products, ZMUni continues to provide practical solutions to help global beauty companies

   On August 3, 2026, China's National Medical Products Administration (NMPA) issued Announcement No. 72 of 2026, , releasing two new complementary testing methods for cosmetics: Determination of Diclofenac Sodium in Cosmetics (BJH 202601) and Determination of Urotropin in Cosmetics (BJH 202602).      Determination of Diclofenac Sodium in Cosmetics This method specifies the qualitative and quantitative determination of diclofenac sodium (CAS No. 15307-79-6), a commonly used non-steroidal anti-inflammatory drug (NSAID) ingredient, in cosmetics. It is applicable to liquid (water- and oil-based), cream/lotion, and gel cosmetic products.     Determination of Urotropin in Cosmetics This method specifies the qualitative and

The global cosmetics regulatory environment continues to evolve. To help businesses stay updated with regulatory changes, ZMUni Compliance Center regularly releases a monthly recap of global cosmetics regulations. This article covers the regulatory developments related to cosmetics in China and globally in June 2026, with an emphasis on updates in cosmetic ingredients and cosmetic management, among other areas.     China Cosmetic Regulatory Updates New Cosmetics Ingredients (NCI)   In July 2026, 18 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include:   The technical requirements for the 18 NCIs mentioned above have not

  From July 21 to 31, a total of five new cosmetic ingredients completed notification with China's National Medical Products Administration (NMPA). The technical requirements for all related NCIs have not yet been publicly disclosed. Notably, four of the five notified NCIs are peptides, comprising three cyclic peptides and one polypeptide.     3'-Sialyllactose sodium salt   3'-Sialyllactose sodium salt (3'-SL) is composed of N-acetylneuraminic acid (Neu5Ac, also known as sialic acid), galactose, and glucose. As a human milk oligosaccharide (HMO), 3'-SL has been approved by authorities such as the US and EU for use in infant formula and other

  On July 29, 2026, China's National Medical Products Administration (NMPA) issued Announcement No.70 of 2026 on Matters Related to Cosmetic Registration and Notification Management.   The Announcement introduces eight measures to optimize cosmetic registration and notification procedures, covering key areas such as product launches, ingredient management, efficacy evaluation, manufacturing changes, and Responsible Person updates. These measures aim to reduce compliance burdens, improve regulatory efficiency, and support innovation in the cosmetics industry.     Supporting First Launches of International Cosmetic Products   Previously, overseas cosmetic brands applying for product registration or notification in China were required to provide proof that

Entering China's cosmetic market requires a thorough understanding of regulatory requirements, documentation procedures, and compliance obligations. At ZMUni, we help global beauty brands navigate these challenges with professional consulting, transparent communication, and end-to-end regulatory support.   Recently, EDK SPA SOLUTION CO., LTD., a South Korean cosmetic company, shared a recommendation letter highlighting their experience working with ZMUni Compliance Centre.     Overcoming Regulatory Challenges with Professional Guidance   Before entering the Chinese market, EDK faced uncertainties regarding China's cosmetic registration procedures and complex documentation requirements.   Their cooperation with ZMUni began at a regulatory seminar organized by a Korean public institution,